Fda
5 articles tagged “Fda”
Treatment
Learn

Generic Premarin Approved: Cheaper HRT in 2026
FDA approved the first generic conjugated estrogens in 30+ years. Prices, pharmacy availability, and whether to switch from brand Premarin.

FDA Opens TRT Pathway for Low Libido in Men
On April 16, 2026, the FDA asked TRT manufacturers to seek approval for low libido in idiopathic hypogonadism. Here's what it means for patients now.

HRT Black Box Warning Removed: What Changed
The FDA removed black box warnings from HRT products in 2025. Prescriptions surged 184%. Here's what the science says and what to do next.

FDA May Descheduling Testosterone: What It Means
An FDA panel recommends removing testosterone's Schedule III status and expanding access to age-related low T. Here's what changes and what to do now.
All Topics
Women's HRT(47)Protocols(38)Menopause(37)Treatments(32)Safety(26)HRT(23)Perimenopause(17)Womens Hrt(16)Fundamentals(15)Dosing(14)Comparisons(14)Clinical Evidence(13)Lab Testing(13)Timeline & Results(13)Hormones(12)Clinics(12)Research(11)News(10)Access(10)Regulation(10)Side Effects(10)Cardiovascular(9)Estrogen(8)Estradiol(8)Monitoring(8)Results(8)Symptoms(6)Optimization(5)Weight Loss(5)Injections(5)Treatment(5)Fda(5)Mental Health(5)Mood(5)Libido(5)Body Composition(5)2026 Research(4)Pricing(4)Sleep(4)Musculoskeletal(4)Hot Flashes(4)Fertility(4)Stacks(3)Alternatives(3)Troubleshooting(3)DHT(3)Prostate(3)Diagnosis(3)Blood Work(3)Clinical Trials(3)Enclomiphene(3)Cost(3)Telehealth(3)Peptides(3)Bone Density(2)Compounding(2)Aua 2026(2)Injection Sites(2)Gsm(2)Vaginal Estrogen(2)Anxiety(2)Surgery(2)Skin(2)Sarcopenia(2)Joint Pain(2)Testosterone(2)Insomnia(2)Nonhormonal(2)Vasomotor Symptoms(2)Breast Cancer(2)Bloodwork(2)2026(2)Timing(2)Free Testosterone(2)Shbg(2)Womens Health(2)Bone Health(2)Oral TRT(2)Cypionate(2)Pellets(2)Progesterone(2)Hematocrit(2)Insurance(2)Shortage(2)Testing(2)HCG(2)Reviews(2)Management(2)
